UnitedHealth Group Incorporated
General ticker "UNH" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $290.2B (TTM average)
UnitedHealth Group Incorporated follows the US Stock Market performance with the rate: 46.3%.
Estimated limits based on current volatility of 0.9%: low 393.51$, high 400.45$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-06-15, amount 2.32$ (Y2.32%)
- Total employees count: 400000 (-9.1%) as of 2024
- US accounted for 99.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Medical cost estimation, Data integrity, IT system failures, Cybersecurity threats, Regulatory and compliance
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [275.43$, 408.92$]
- 2026-12-31 to 2027-12-31 estimated range: [305.96$, 445.59$]
Financial Metrics affecting the UNH estimates:
- Negative: with PPE of 20.2 at the end of fiscal year the price was high
- Positive: -4.23 < Operating profit margin, % of 4.24
- Positive: Interest expense per share per price, % of 1.34 <= 3.34
- Positive: Inventory ratio change, % of 0.07 <= 0.79
- Positive: 18.97 < Shareholder equity ratio, % of 32.33 <= 42.26
- Positive: 0.28 < Operating cash flow per share per price, % of 6.59
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 3.97
- Positive: Industry inventory ratio change (median), % of 0.22 <= 0.27
- Positive: -9.15 < Industry operating profit margin (median), % of 1.57
- Negative: Industry operating cash flow per share per price (median), % of 3.62 <= 5.56
Short-term UNH quotes
Relationship graph
Long-term UNH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $371,622.00MM | $400,278.00MM | $447,567.00MM |
| Operating Expenses | $339,264.00MM | $367,991.00MM | $428,603.00MM |
| Operating Income | $32,358.00MM | $32,287.00MM | $18,964.00MM |
| Non-Operating Income | $-3,246.00MM | $-12,216.00MM | $-4,267.00MM |
| Interest Expense | $3,246.00MM | $3,906.00MM | $4,002.00MM |
| Income(Loss) | $29,112.00MM | $20,071.00MM | $14,697.00MM |
| Taxes | $5,968.00MM | $4,829.00MM | $1,890.00MM |
| Net Income(Loss)* | $22,381.00MM | $14,405.00MM | $12,056.00MM |
| Stockholders Equity | $94,421.00MM | $98,268.00MM | $100,090.00MM |
| Assets | $273,720.00MM | $298,278.00MM | $309,581.00MM |
| Operating Cash Flow | $29,068.00MM | $24,204.00MM | $19,697.00MM |
| Capital expenditure | $3,386.00MM | $3,499.00MM | $3,622.00MM |
| Investing Cash Flow | $-15,574.00MM | $-20,527.00MM | $-8,685.00MM |
| Financing Cash Flow | $-11,529.00MM | $-3,512.00MM | $-11,644.00MM |
| Earnings Per Share** | $24.12 | $15.51 | $13.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.